Literature DB >> 27916317

High intratumoural but not peritumoural inflammatory host response is associated with better prognosis in primary resected oesophageal adenocarcinomas.

Alexandra V Stein1, Bastian Dislich1, Annika Blank1, Lars Guldener1, Dino Kröll2, Christian A Seiler2, Rupert Langer3.   

Abstract

The host inflammatory response plays an important role in many solid malignancies. Studies on oesophageal adenocarcinomas (EACs) point towards a beneficial role of pronounced immunoreaction, however, congruent results have yet to be obtained. We analysed 111 primary resected EAC using a tissue microarray containing three cores of the tumour centre and the periphery per case. Overall inflammation was assessed by histomorphology. Tumour infiltrating lymphocytes (TILs) were characterised by immunohistochemistry for CD3, CD8 and FoxP3, and evaluated by image analysis (Aperio ImageScope). High levels of inflammation in the tumour centre, but not the periphery were associated with better patient survival (p = 0.001), similar to high counts of intratumoural FoxP3+, CD3+, CD8+ TILs (p = 0.001; p = 0.027; p = 0.038) and a combination of CD3+/CD8+/FoxP3+ TILs, the latter displaying three different prognostic groups (triple high/mixed/triple low; p=0.003). Intratumoural inflammation [hazard ratio (HR) = 0.432; p = 0.030], FoxP3+ TIL counts (HR = 0.411; p = 0.033) and the combination CD3+/CD8+/FoxP3+ TILs (HR = 0.173; p = 0.006) were also independent prognostic parameters. In summary, both high grade total inflammation and high TIL counts in the tumour centre, but not the tumour periphery, show a beneficial prognostic impact on EAC. This may be a target for novel therapeutic options but also serves as prognostic indicator in these tumours.
Copyright © 2016 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD3; CD8; FoxP3; Oesophageal adenocarcinoma; inflammation; tumour infiltrating lymphocytes

Mesh:

Substances:

Year:  2016        PMID: 27916317     DOI: 10.1016/j.pathol.2016.10.005

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  12 in total

1.  Type II and III adenocarcinoma of the esophago-gastric junction: esophageal extent ≥1.5 cm critical for mediastinal nodal disease.

Authors:  Gerhard G Grabenbauer
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

2.  IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.

Authors:  Guanglin Cui; Zhenfeng Li; Jingli Ren; Aping Yuan
Journal:  Virchows Arch       Date:  2019-05-06       Impact factor: 4.064

3.  Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction.

Authors:  Bastian Dislich; Dino Kröll; Rupert Langer
Journal:  Updates Surg       Date:  2022-08-24

4.  Prognostic value of tumor-infiltrating lymphocytes in esophageal cancer: an updated meta-analysis of 30 studies with 5,122 patients.

Authors:  Yibo Gao; Wei Guo; Xiao Geng; Yidong Zhang; Guochao Zhang; Bin Qiu; Fengwei Tan; Qi Xue; Shugeng Gao; Jie He
Journal:  Ann Transl Med       Date:  2020-07

Review 5.  Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis and experimental validation.

Authors:  Nana Zhang; Meng Cao; Yixin Duan; Haixia Bai; Xiang Li; Yili Wang
Journal:  Arch Med Sci       Date:  2019-09-09       Impact factor: 3.318

Review 6.  The tumour immune microenvironment in oesophageal cancer.

Authors:  Maria Davern; Noel E Donlon; Margaret R Dunne; Robert Power; Conall Hayes; Ross King; John V Reynolds
Journal:  Br J Cancer       Date:  2021-04-26       Impact factor: 7.640

7.  Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus.

Authors:  M Schoemmel; H Loeser; F Gebauer; A Quaas; M Kraemer; S Wagener-Ryczek; A Hillmer; C Bruns; M Thelen; W Schröder; T Zander; A Lechner; R Buettner; H Schlösser
Journal:  Clin Transl Oncol       Date:  2021-02-10       Impact factor: 3.405

8.  Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival.

Authors:  Karl-Frederick Karstens; Jan Kempski; Anastasios D Giannou; Penelope Pelczar; Babett Steglich; Stefan Steurer; Eric Freiwald; Anna Woestemeier; Leonie Konczalla; Michael Tachezy; Matthias Reeh; Maximilian Bockhorn; Daniel Perez; Oliver Mann; Ansgar W Lohse; Thomas Roesch; Jakob R Izbicki; Nicola Gagliani; Samuel Huber
Journal:  Cancer Immunol Immunother       Date:  2020-02-25       Impact factor: 6.968

Review 9.  Methods to Determine and Analyze the Cellular Spatial Distribution Extracted From Multiplex Immunofluorescence Data to Understand the Tumor Microenvironment.

Authors:  Edwin Roger Parra
Journal:  Front Mol Biosci       Date:  2021-06-14

10.  A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.

Authors:  Olivia Adams; Félice A Janser; Bastian Dislich; Sabina Berezowska; Magali Humbert; Christian A Seiler; Dino Kroell; Julia Slotta-Huspenina; Marcus Feith; Katja Ott; Mario P Tschan; Rupert Langer
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.